MB "Biotechnologinių tyrimų centras" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 40,236 |
| 13,412 |
| -6,267 |
| -6,267 |
| -2,089 |
| 47.68 |
| -15.58 |
| 1,365 |
| 11,080 |
| 3,252 |
| 9,193 |
| 2023 |
|---|
| 79,970 |
| 26,657 |
| 6,093 |
| 5,814 |
| 1,938 |
| 19.52 |
| 7.27 |
| 7,179 |
| 3,655 |
| 3,032 |
| 7,802 |
| 2024 |
|---|
| 51,297 |
| - |
| 3,828 |
| 3,715 |
| - |
| 16.46 |
| 7.24 |
| 10,894 |
| 10,174 |
| 2,813 |
| 18,255 |
Register and
explore Okredo data| 2024 |
|---|
| 51,297 |
| - |
| 3,828 |
| 3,715 |
| - |
| 16.46 |
| 7.24 |
| 10,894 |
| 10,174 |
| 2,813 |
| 18,255 |
Register and
explore Okredo data2024
Turnover (€)
51,297 €
-36 % *
Sales per employee (€)
-Profit before tax (€)
3,828 €-37 % *
Net Profit (€)
3,715 €-36 % *
Profit per employee (€)
-Total profitability (%)
16.46 %-15.68 % *
Net profitability (%)
7.24 %-0.41 % *
Equity (€)
10,894 €
52 % *
Amounts Payable And Liabilities (€)
10,174 €
178 % *
Non-current Assets (€)
2,813 €
-7 % *
CurrentAssets (€)
18,255 €134 % *